Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP611215.RAdpH8fY4c4VZAnjE8hzUW5A53Q5jDaAVtaXkH5GWtb6o130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP611215.RAdpH8fY4c4VZAnjE8hzUW5A53Q5jDaAVtaXkH5GWtb6o130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP611215.RAdpH8fY4c4VZAnjE8hzUW5A53Q5jDaAVtaXkH5GWtb6o130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP611215.RAdpH8fY4c4VZAnjE8hzUW5A53Q5jDaAVtaXkH5GWtb6o130_provenance.
- befree-20150227 importedOn "2015-02-27" NP611215.RAdpH8fY4c4VZAnjE8hzUW5A53Q5jDaAVtaXkH5GWtb6o130_provenance.
- NP611215.RAdpH8fY4c4VZAnjE8hzUW5A53Q5jDaAVtaXkH5GWtb6o130_assertion wasGeneratedBy ECO_0000203 NP611215.RAdpH8fY4c4VZAnjE8hzUW5A53Q5jDaAVtaXkH5GWtb6o130_provenance.
- NP611215.RAdpH8fY4c4VZAnjE8hzUW5A53Q5jDaAVtaXkH5GWtb6o130_assertion wasDerivedFrom befree-20150227 NP611215.RAdpH8fY4c4VZAnjE8hzUW5A53Q5jDaAVtaXkH5GWtb6o130_provenance.
- NP611215.RAdpH8fY4c4VZAnjE8hzUW5A53Q5jDaAVtaXkH5GWtb6o130_assertion SIO_000772 19417023 NP611215.RAdpH8fY4c4VZAnjE8hzUW5A53Q5jDaAVtaXkH5GWtb6o130_provenance.
- NP611215.RAdpH8fY4c4VZAnjE8hzUW5A53Q5jDaAVtaXkH5GWtb6o130_assertion evidence source_evidence_literature NP611215.RAdpH8fY4c4VZAnjE8hzUW5A53Q5jDaAVtaXkH5GWtb6o130_provenance.
- NP611215.RAdpH8fY4c4VZAnjE8hzUW5A53Q5jDaAVtaXkH5GWtb6o130_assertion description "[Combined PCI-24781/bortezomib treatment resulted in strong synergistic apoptosis in all non-Hodgkin lymphoma lines (combination indices, 0.19-0.6) and was additive in Hodgkin lymphoma and primary CLL/SLL cells.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP611215.RAdpH8fY4c4VZAnjE8hzUW5A53Q5jDaAVtaXkH5GWtb6o130_provenance.